DOCSLIB.ORG

Getinge 2018 Annual Report

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Getinge 2018 Annual Report Passion for life 2018 Annual Report CONTENTS Passion for life Introduction This is Getinge 1 Year in brief 2 Sometime in life, we all need to seek healthcare. At Comments by the CEO 6 Getinge, we have a long tradition of creating innovations that improve people’s quality of life – and save lives. We Business environment think it is the most important job in the world. and market trends Global value creation 10 Trends and business drivers 12 Market overview 14 Strategy and targets Strategy 18 Targets 20 R&D 22 Sales 24 Quality 25 Operations Acute Care Therapies 28 Surgical Workflows 32 Life Science 36 Sustainability Sustainable value creation 42 Ethics 46 Employees 48 Environment 50 Annual Report Administration Report 52 Corporate Governance Report 56 Proposed appropriation of profit 66 Financial statements 67 Notes 72 Auditor’s report 115 Other information Sustainability notes 119 GRI index 122 The share 124 Multi-year overview 126 Group companies 131 Definitions 135 Every care has been taken in the translation of this Annual Report. In the event of discrepancies, the Swedish original will supersede the English translation. Cover: Mickaël Fresnay and Jason Courtin, DPTE® Transfer System Fitters at Getinge’s production facility in Vendôme, France. 2018 ANNUAL REPORT Introduction Market Strategy Operations Sustainability Annual Report Other This is Getinge The world is facing major challenges, one of which is the possibility to provide people with high-quality and effective healthcare. The Earth’s population is increasing, while we are also living longer, which increases the pressure on healthcare. According to the WHO, lifestyle diseases, such as cardiovascular diseases are one of the primary causes of death in the world. The risk of being exposed to infection, outside or within the hospital environment, also impacts our everyday life. Getinge is deeply committed to finding solutions to these challenges and thereby enhancing people’s quality of life. This is achieved by Getinge providing its customers with the necessary knowledge, technology and resources to achieve the optimal clinical outcomes and, ultimately, to save lives. How Getinge contributes We work to ensure that all people and society have access to the best possible healthcare. We contribute to this through improvements for patients and professionals in hospitals and institutions in life science using technology, infrastructure design and workflow expertise. In addition, we are at our customers’ side, ready to provide technical support, training, on-site consultation and financial ser- vices. Our operations are conducted in the following three business areas. 25,000 Acute Care Therapies No. of customers The offering contains solutions for cardiac, pulmonary and vascular therapies, and a broad selection of technologies and therapies for life support in acute health conditions, as well as respirators for mobile ventilation, and portable, 24.2 acute treatment of cardiac and pulmonary patients. Surgical Workflows Net sales (SEK billion) Products and solutions to optimize quality, safety and capacity use of sterilization departments and operat- ing rooms. The product portfolio contains, for example, operating tables and lights and systems for the cleaning, disinfection and sterilization of instruments, and advanced 4.9% hospital IT systems. Organic growth in Life Science net sales Equipment, technical expertise and consultation to prevent contamination in pharmaceutical and medical device production. The business area also works to ensure research integrity in biomedical research and in simplifying qualification processes. 2018 ANNUAL REPORT 1 Passion for life 2018 in brief New business area – Life Science The Life Science organization, which was formerly part of Surgical Workflows, has been a separate business area since January 1, 2018. Launch of the S-8668T washer-disinfector A new model in the 86 washer-disinfec- tor series, the S-8668T, was launched in September with the aim of improving the cleaning capacity in central sterile supply departments. The turbo technology, with multitasking function, in the S-8668T means that the processing time can be reduced by up to 25%, leading to increased productivity and reduced environmental impact. Flow-c – a new anesthesia machine New patient transfer system In June, a new, compact anesthesia for the multifunctional hybrid machine was launched for the safe and operating room cost-effective treatment of patients. Flow-c PILOT, the very first patient transfer is based on the reputable Servo ventilator solution for multi-modality operating and the same innovative technology as rooms, was presented in May. The new Flow-i, which ensures superior ventilation patient-centered transfer system enables performance, with the power and precision the transfer of patients between imaging required for all patient categories. systems and treatment rooms without GSS Sterilizer series for Life Science repositioning. PILOT is part of many In June, two models of sterilizers were innovative results of Getinge’s strategic launched for customers in Life Science. partnership with Siemens Healthineers. GSS R is aimed at biomedical research and GSS P at pharmaceutical production. Result of EOLIA study Provision for and divestment of biosurgery business The ECMO to Rescue Lung Injury in Severe In October, Getinge announced a provision of SEK 1.8 billion for expected costs associated ARDS (EOLIA) trial was the first randomized with the liability claims filed in the US and Canada against the subsidiary Atrium Medical’s multicenter trial with ECMO at 64 centers surgical mesh implants, which are used, for example, in the surgical treatment of hernias. The worldwide. The results demonstrated that suits consist of individual lawsuits, consolidated state cases and consolidated multi- the care of the patient with appropriate ven- district federal litigations. The first trials are expected to take place in late 2019 and early tilation management combined with planned 2020. The biosurgery business will be divested to HJ Capital 1, parent company of SeCQure early extra corporeal membrane oxygenation Surgical Corporation, conditional upon the customary official approval and other condi- (ECMO) is an effective strategy for treatment tions of completion. of patients suffering from severe acute respi- ratory distress syndrome (ARDS). 2 2018 ANNUAL REPORT Introduction Market Strategy Operations Sustainability Annual Report Other New President of Surgical Workflows business area Key figures 2018 2017 Stéphane Le Roy was appoint- Order intake, SEK M 24,347 23,228 ed President of the Surgical Workflows business area and Net sales, SEK M 24,172 22,495 joined the Getinge Executive Adjusted EBITA (SEK M) 2,689 3,108 Team in November. Stéphane Adjusted EBITA margin, % 11.1 13.8 Le Roy most recently served as the Regional President of South Adjusted earnings per share, SEK 5.91 7.87 West Europe within Getinge’s Net debt/equity ratio, multiple 0.64 0.65 global sales organization. Equity/assets ratio, % 45.3 47.0 Equity per share, SEK 72.16 72.72 Synthetic options Organic growth in net sales All Board members elected by the AGM and all members of the % Getinge Executive Team received an offer in May to purchase syn- thetic options in Getinge issued by Carl Bennet AB. Getinge will 5 In 2018, Getinge’s sales increased have no costs related to the program. A total of 3,153,889 synthetic 4 by 7.5%, of which 4.9 % organically, which is a growth rate not seen for options were acquired at a price considered to correspond to the 3 many years. For the year before, market value. The market value of the options at the time of the 2 2017, organic growth was 1.3%. transaction was estimated to be approximately SEK 21.8 M. 1 2017 2018 Sales per region Americas, 39% (SEK 9,530 M) EMEA, 39% (SEK 9,439 M) APAC, 22% (SEK 5,203 M) A bright future – Maquet PowerLED II To strengthen the offering of operating room lighting, Maquet Sales per business area PowerLED II was launched, featuring world-leading technology that improves working conditions for surgeons and hospital personnel. Acute Care Therapies, 54% (SEK 13,013 M) Agreement with the Brazilian Life Science, 9% Federal Public Prosecutor's Office (SEK 2,194 M) Getinge reached an agreement with the Brazilian Federal Public Surgical Workflows, 37% Prosecutor’s Office (Ministério Público Federal) on a Leniency (SEK 8,965 M) Agreement mainly related to the manipulation of tender proce- dures by Getinge’s subsidiary in Brazil in 2004-2015. The agreement entails that Getinge will pay a company fine corresponding to approximately SEK 276 M (BRL 121.8 M). The amount is covered by the provision announced in March 2018. Read more about this in the Administration Report. 2018 ANNUAL REPORT 3 Passion for life Getinge’s solutions address the challenge that today’s bypass patients have a high risk profile. 4 2018 ANNUAL REPORT Introduction Market Strategy Operations Sustainability Annual Report Other CASE – BYPASS Solutions that save hearts every day In the case of coronary stenosis, medication or stents are often the primary treatment option. However, sometimes a bypass operation is required. Getinge’s broad product portfo- lio and comprehensive knowledge bank have solutions that facilitate each step of the treatment. Bypass is the most common surgery challenge that today’s bypass patients have conducted by heart surgeons the world a high risk profile due to other diseases over. This is a major procedure, with the that coexist with coronary artery disease, patient often being admitted the day before which could lead to increased surgical the operation and it can take time to fully complexity, greater risk of complications recover afterwards. During the operation, and higher healthcare costs. the patient is under anesthetic and a heart- The portfolio offers equipment and aids lung machine is also often used. for all stages of the bypass procedure The procedure entails that new blood – both the preparatory work, the actual vessels are connected to the heart by being operation and the post-operative care in sown to the coronary artery, beyond the the intensive care unit.
Load more

Recommended publications
  • A ABB Group Advantage Global Trade Solutions AF Consult Ahlstrom
    A CFAO ABB Group China Systems Advantage Global Trade Solutions Chromafora AF Consult Citi Ahlstrom Munksjö ClimeOn Airbus Group Coface Aker Solutions Collector Bank Alfa Laval Credit Agricole Corporate & Investment Alimak Group Bank Andritz ANZ D Aon Danieli Archer Daniels Midland Danske Bank AS Arjo Huntleigh DeLaval Arthur J. Gallagher Deutsche Bank Atlas Copco DNB Bank Atradius Doranova AXA Group E B Eitech Bank ABC EKF Barak Fund Management Ekman & Co. Barclays EKN BillerudKorsnäs Elekta BNP Paribas Elof Hansson BNY Mellon Envac Bolero International Epiroc BPL Global Ericsson Brim Essity Bunge ESSWELL International Bureau van Dijk Euler Hermes Business Sweden F C Finnvera Camfil Flir Canopius FLSmidth CellMark Fortex International Cellmark G Metso Corporation Geodis MG Systemes Getinge Group Microsoft Corporation GIEK Mitigram GKN Aerospace Mizuho Bank Global Trade Corporation GTR N Gunnebo Treasury NatWest NCC H Nederman Handelsbanken NEOT Holmen Nokia Howden Sweden Nordea HSBC Nordic Investment Bank Hydro Aluminium Normet Group Nynas I IBM O ICC OCP Group ING OP Financial Group Interspiro Outokumpu Investec Outotec J P JLT Paulig Group John Bean Technologies Corporation Ponsse Price & Pierce K Kalmar Industries R Konecranes Raiffeisen Bank International Kongsberg Gruppen RKH Specialty Korab International Rolling Optics L S LEAP Export Finance Saab Lego Group Sandvik Sasa M Scania Marsh SEB McLaren SEK Setra Y Siemens Yapi Merkezi Siemens Financial Services Yara International SKF YIT Skov SMT Group Z Société Générale Zurich Credit & Political Risk SSAB Standard Chartered Stora Enso Sumitomo Mitsui Banking Corporation Surecomp Svenska Handelsbanken Swedafrica Consulting Swedbank Swift T Taurus fondas TD Bank Group Tellux Africa The Channel Syndicate The Game Changer Global Initiative TradeIX V Väderstad Valmet Vattenfall Volvo Group W we.trade Wells Fargo Willis Towers Watson X XL Catlin .
    [Show full text]
  • Sweden - India Business Guide
    3 BUSINESS GUIDE SWEDEN - INDIA SWEDEN SWEDEN - INDIA BUSINESS GUIDE 2 SWEDEN - INDIA BUSINESS GUIDE Disclaimer: The Embassy of Sweden, Consulate General of Sweden, Business Sweden and Swedish Chamber of Commerce India have made every effort to provide a comprehensive directory of companies with substantial Swedish interest represented in India, and companies with substantial Indian interest represented in Sweden. However, the Embassy cannot guarantee that the list is exhaustive. All company information contained in this directory has been provided by the companies themselves. Copyright (c) May 2017, Embassy of Sweden 4 1 Table of Contents Foreword 5 Team Sweden 7 Country Facts - Economy Trade and Investments 17 Core Values 31 Platforms 43 Partners 59 Business Directory 63 Swedish Prime Minister Stefan Löfven and Indian Prime Minister Narendra Modi in Mumbai 2 3 Foreword Sweden Makes in India! Ties between Sweden and India continue to environment and smart cities, ICT and grow stronger. We see intensified relations digitalization, as well as healthcare and life in a range of areas of mutual benefit and sciences. Sweden believes in knowledge- an increasing exchange of high-level visits based societies, powered by innovation and in both directions. The Make in India Week sustainability, while investing in people. In in Mumbai in 2016 saw the creation of a this, India and Sweden are ideal partners in permanent platform for business leaders, building sustainable business for the future. the India Sweden Business Leaders’ Round Table. In this eighth edition of the Sweden – India Business Guide, we highlight the core values Swedish companies have been Making in and key competencies that Sweden offers India for many decades and today create 185 India in a strategic partnership.
    [Show full text]
  • 56Th Annual Meeting O Fficers and Council 5 Corporate Supporters Committee Members 6 Gl O D Past Meetings of the STSA 7
    SOU THERN THORACIC STSA SURGICAL ASSOCIatION 56 TH ANNUAL MEETING NOVE MBER 4 - 7, 2009 Marco Island Marriott Beach Resort Marco Island, Florida SPECI AL THANKS ta BLE OF CONTENTS SPECIAL THANKS TO STSA 56TH ANNUAL MEETING O FFICERS AND COUNCIL 5 CORPORATE SUPPORTERS COmmITTEE MEMBERS 6 GL O D PAST MEETINGS OF THE STSA 7 Medtronic CLIFFORD VAN METER PRESIDENT’S AWARD 8 www.medtronic.com TIKI AWARD 9 St. Jude Medical OSLER ABBOTT AWARD 10-11 www.sjm.com KENT TRINKLE EDUCATION LECTURESHIP 11 SILVER HAWLEY H SEILER, M D RESIDENT AWARD 12 Ethicon Endo-Surgery, Inc. MAVROUDIS-URSCHEL AWARD 12 www.ethiconendo.com STSA INSPIRATION AWARD 13 Maquet Cardiovascular www.maquet.com CONTINUING MEDICAL EDUCATION OVERVIEW 14-15 DISCLOSURE POLICY 16-17 SCHEDULE OF EVENTS 18-20 SCHEDULE OF ACTIVITIES 21-22 SURGICAL MOTION PICTURES 23 POSTGRADUATE PROGRAM 24-26 SCIENTIFIC SESSIONS 27-44 BASIC SCIENCE FORUM 30 GENERAL SESSION 33 CODING UPDATE AND ETHICS FORUM 40 HISTORY PRESENTATION 43 SCIENTIFIC PAPERS 45-203 EXHIBITORS 204-209 NECROLOGY REPORT 211 HONORARY MEMBERS 212 MEMBERSHIP ROSTER 213-312 GEOGRAPHIC LISTING OF MEMBERS 313-329 CONSTITUTION AND BYLAWS 330-341 RELATIONSHIP DISCLOSURE INDEX 342-350 INDEX OF AUTHORS 352-356 2 STSA 56th Annual Meeting STSA 56th Annual Meeting 3 F UTURE MEETING LOCATIONS 2009F OF ICERS AND COUNCIL N OVEMBER 3-6, 2010 P RESIDENT Disney Yacht & Beach Club Michael J Mack, MD Orlando, FL Dallas, TX NOVEMBER 9-12, 2011 PRESIDENT-ELECT JW Marriott San Antonio Hill Keith Naunheim, MD San Antonio, TX St. Louis, MO NOVEMBER 7-10,
    [Show full text]
  • ANNUAL REPORT 2020 ANNUAL REPORT 3 Introduction Q the Year in Brief the Year in Brief Q Introduction
    Passion for life 2020 Annual Report This is Getinge Q Introduction CONTENTS Introduction Passion for life This is Getinge 1 Global value creation 2 Sometime in life, we all need to seek health care. At The year in brief 4 Getinge, we have a long tradition of creating innovations CEO Interview 6 that improve people’s quality of life – and save lives. We Trends and business drivers 8 think it is the most important job in the world. Strategy Targets 12 Strategy for sustainable growth 14 Sustainability framework 18 Operations Market overview & sales 31 Acute Care Therapies 34 Life Science 38 Surgical Workflows 42 Annual Report Administration Report 47 Corporate Governance Report 56 Board of Directors 69 Getinge Executive Team 72 Guidelines for remuneration 74 Remuneration Report 79 Proposed appropriation of profit 82 Group Financial statements 83 Notes 88 Parent Company Financial statements 120 Notes 124 Auditor’s report 131 Other information Sustainability notes 136 GRI index 147 The Getinge share 150 Multi-year overview 152 Group companies 158 Definitions 162 Getinge adds value to THIS IS GETINGE customers’ operations in terms of The world is facing major challenges, one of which is the ability to provide 25,000 10,800 the increasing world population with safe and effective health care. We live longer and, according to WHO, lifestyle diseases such as cardiovascular Improved No. of customers No. of employees in the company diseases are one of the primary causes of death globally. clinical outcomes Getinge is committed to ensuring that all people and societies have access to the best possible health care.
    [Show full text]
  • NORDIC INVESTMENT BANK DECEMBER 2008 Winds of Change
    NORDIC INVESTMENT BANK DECEMBER 2008 Winds of change Danish DONG Energy is building the world’s largest offshore wind turbine park Financing environmental action CLEERE and BASE lending facilities in operation BULLETIN DECEMBER 2008 4 Where the wind blows The world’s largest offshore wind turbine park CONTENTS NIB in in the making 7 Moventas: favourable winds good and Finnish wind turbine manufacturer expanding production 8 Latvenergo’s investments address climate change LETTER FROM THE PRESIDENT LETTER FROM bad times 10 Baltic Sea needs political commitment THE PRESIDENT LETTER FROM Interview with Ambassador Ole Norrback 11 NIB’s environmental lending facilities in operation 12 Environmental investments in Ukraine authorities providing both liquidity and capital have served to prevent a collapse 14 Amber One of the financial system, but the financial Building Europe’s new north-south corridor sector is clearly not performing its KI Ä normal function of intermediating M U 16 Getinge grows for cost efficiency savings into investments. OIV This has shed new light on the role K 18 Gauging competitiveness calls for expertise of the IFIs. On the one hand, their good ARJO Interview with Martin Carlens, NIB’s Head of Mandate standing in the financial markets has, at : M least so far, provided stable access to the HOTO 20 Competitiveness in focus funding markets, which has enabled P them to fill some of the gaps that the Projects in Denmark, Estonia and Norway private sector has been unable or The role of and the need for Interna- adjust their resources to a lower level of unwilling to fill in the new situation.
    [Show full text]
  • Determinant Influence on Hedging Strategies
    Determinant Influence on Hedging Strategies A case study of AB Volvo, AB SKF and Getinge AB Degree Project in Master of Science in Business and Economics, specialization in Industrial and Financial Economics, 30.0 credits Authors: Linn Birnbo & Sofie Wernersson Determinant Influence on Hedging strategies Abstract Type of thesis: Degree Project in Master of Science in Business & Economics; specialization in Industrial and Financial Management, 30.0 credits University: School of Business Law and Economics at University of Gothenburg Semester: Spring 2013 Authors: Linn Birnbo and Sofie Wernersson Advisor: Einar Bakke Title: Determinants Influence on Companies’ Hedging Strategy – A Case Study of AB Volvo, AB SKF and Getinge AB Background and Problem: Most internationally operating companies are exposed to foreign exchange risk. Companies who hedge their currency exposure strive to minimize the effect of unfavourable foreign exchange rate movements since it can have a negative impact on companies’ operational results. However, there is no optimal hedging theory that can guide managers to reduce this company specific risk. Due to a lack of knowledge and an insufficient understanding in companies about ways to prevent this, companies constantly need to update and reform their hedging strategies. Therefore, it is important to recognise which, how and why internal and external determinants affect companies’ hedging strategies. Aim of Study: The aim of this study is to explore which determinants have affected AB Volvo, AB SKF and Getinge AB’s currency risk management during the last decade. Furthermore, it should aim to answer how and why the companies’ hedging strategies have been influenced by these determinants.
    [Show full text]
  • Corporate Governance Report
    ADMINISTRATION REPORT Corporate Governance Report Getinge AB (publ) is a Swedish public lim- include Getinge AB’s Articles of Associa- Board members as well as the auditor’s ited liability company listed on Nasdaq tion, instructions and formal work plan for term of office Stockholm, Large Cap segment. Getinge the Board of Directors, Board committees • Adoption of the remuneration to applies the Swedish Corporate Gover- and CEO, various policies and guidelines Board members and auditor nance Code and hereby presents the as well and the Group’s Code of Conduct. • Reelection of all Board Members and Corporate Governance Report for 2016. The company’s Articles of Association are election of Johan Malmquist as a new available on the Group’s website: Board member Introduction www.getinge.com. • Reelection of Carl Bennet as Chairman Getinge Group is a global company in the of the Board medical device field with operations in 44 Shareholders • Reelection of Öhrlings Pricewater- countries and proprietary production in For information about shareholders and houseCoopers AB as auditor for Get- 11 countries. the Getinge share, see pages 40–41 inge until the conclusion of the 2017 The Group’s customers are found pri- and www.getinge.com. AGM marily in the healthcare, elderly care and • Guidelines for the remuneration to life science areas, and the Group’s prod- General Meeting of Shareholders senior executives ucts are often pivotal to the quality and Shareholders can exert their influence at • Establishment of the long-term share- efficiency of customers’ businesses. the Annual General Meeting (AGM) and, based incentive program, LTIP 2016, and Accordingly, confidence in Getinge and its when applicable, at an Extraordinary Gen- hedging activities in view of the pro- products is entirely decisive for continued eral Meeting, which are Getinge’s highest gram through amendments of the Arti- sales successes.
    [Show full text]
  • Getinge Ab Annual Report 2011 Atrium Medical Sales Organic Growth Number of Employees
    geTinge ab annual reporT 2011 Atrium Medical Sales Organic growth Number of employees 200 19% 700 USD million three­year average total, worldwide A rapidly expanding company in the dynamic cardiovascular market The acquisition of the US company Atrium Medical was completed on 1 November 2011. Atrium is the latest addition to the Medical Systems Business Area’s cardio­ vascular operations. Atrium has an impressive track record and since the company was founded in 1981, it has grown rapidly, particularly over the past three years for which organic growth averaged 19% annually. The headquarters is in Hudson, New Hampshire in the US and the US market accounts for 70% of sales. The remaining 30% is through proprietary sales offices in the UK, Germany, France, the Netherlands, India, Australia and New Zealand as well as via a network of international distributors. The first product launched by Atrium was a drainage product used for open cardiovascular and thoracic surgery to remove air and fluids from the thoracic cavity and thus maintain normal respiratory function. The product is principally used for operations following severe A V12 covered stent used to repair ruptured traumas such as traffic accidents. arteries. Following this first product, Atrium has continued to develop a range of products, including synthetic vascular implants and stents using polytetrafluoroethylene (PTFE). The use of PTFE provides a number of advantages. For example, stents covered with PTFE can be rapidly inserted in the correct position to repair a ruptured artery through an operation of a minimal invasive nature. Recently, Atrium started to utilise Omega­3 fatty acids in the surgical treatment of hernias.
    [Show full text]
  • Corporate Governance Report
    CORPORATE GOVERNANCE ELEKTA ANNUAL REPORT 2020/21 71 CORPORATE GOVERNANCE / CHAIRMAN’S comment Increased importance and attractiveness of radiotherapy Elekta is a key industrial partner to cancer care and healthcare providers globally. Cancer is the fastest growing healthcare burden in society and the first or second leading cause of death globally. Over the last 18 months the pandemic has forced hospitals and clinics to reprioritize resources and to restrict access for installations and treatments. Elekta has shown strong resilience, both financially and operationally, and has been able to continue supporting customers in keeping cancer care going. Even so, the lack of resources brought by the pandemic will leave long-lasting marks as diagnosis and treatment for millions of cancer patients have been delayed. The importance of cancer care and the long-term attrac- tiveness of the radiation therapy market was underscored by Siemens Healthineers’ re-entry to our industry. This change in the competitive landscape strengthens Elekta’s long-held tradition of bringing diagnostic imaging to radiotherapy and will spur technological and clinical innovations. The role of radiotherapy in cancer care has successively grown “The change in the as clinical and technological innovations brought to market. Elekta has improved patient outcomes and improved precision of both diagnosis and treatment. We are dedicated to continuously competitive landscape improve cancer care and making the treatments better, safer and more effective. Our strategic partnership with Philips will further strengthens Elekta’s long- unlock opportunities in the broader cancer care spectrum. Glob- ally, there is still a substantial shortage of radiotherapy capacity. held tradition of bringing Especially low- and middle-income countries are severely under- served.
    [Show full text]
  • Final Source to Pay Summit 2017 Program
    March 29th | drinks & dinner March 30th | Main Conference Hotel Birger Jarl, Stockholm www.source2pay-summit.com Speakers 2017 source to paysource summit Benny Hall Jerker Jenedahl Kristin Ang Irene Tibbling, Elina Rääsk VP & CPO Indirect VP & Head of Shared Group Purchasing Sourcing development Corporate Purchasing Services Strategy & Business & controlling Responsibility Manager, Transformation Procurement Quality Manager Expert Organizations Theme Discussion Moderators Frida Linder Mats Johansson Peter Böhm Marc Vergroesen Ann-Louise Hallding Nina Kivioja Nicola Gianluca Kati Leppänen Global Process BPO Contract Manager, Director Purchasing, Manager | Sourcing & Procurement Director, Sourcing - Raimondi Development manager, Owner PTP, Finance Trelleborg Industrial Procurement Process Development Indirect Material and Indirect Global Procurement Finance Solutions Excellence Specialist | Group Services Sourcing Senior Procurement Director Benny Hall Jerker Jenedahl Cristian Stefanescu René Wienmann Loic Fresne Irene Tibbling Elina Rääsk Brian Sørensen Håkan Hultén VP & CPO VP & Head of Global Process Director, Global Head of Sr Director, Head of Sourcing development & Corporate Global Category Group Purchasing Indirect Shared Services Owner Source-to- Indirect Sourcing & Global Procurement controlling Responsibility Manager, Director Business Process and Purchasing Pay and Order-to- Procurement Procurement Quality Transformation Manager Cash A big Thank You to all who joined S2P in 2016! ÅF, Volvo Car Group, Vestas Wind Systems, Veidekke
    [Show full text]
  • 2018 Participating Organizations
    2018 Participating Organizations 3M Company Albert Einstein College of Medicine, Inc. 7‐Eleven, Inc. Alerus Financial Corporation A. O. Smith Corporation Alfa Laval, Inc. A. O. Water Treatment Alfa Mutual Insurance Company A123 Systems LLC All Nippon Airways Co., Ltd. AAA Club Alliance Inc. Allegis Group AAA National Office Alliance Data Systems ‐ Card Services AAA Northern California, Nevada and Utah Alliant Energy Corporation Aaron's Inc. Allianz Asset Management of America L.P. Abbott Laboratories ‐ Nutrition Allied Motion Technologies, Inc. Abloy Security, Inc. Allina Health System ABRA Auto Body & Glass Allina Health System ‐ New Ulm Medical Center Abt Associates, Inc. Allnex Group Accenture, Inc. Allnex USA Inc. Accolade Ally Financial, Inc. Accolade Wines North America, Inc. Alorica AccorHotels NA Alto‐Shaam ACH Food Companies, Inc. Altria Group, Inc. ACUITY Alyeska Pipeline Service Company Acushnet Holdings Corporation Alys Beach Adidas America, Inc. Amazing Grass Adient US LLC Amazon.com ADT, LLC Amcor Rigid Plastics Advance Auto Parts, Inc. Amedisys, Inc. Advance Local AMERICA CENTRAL CORPORATION Advanced Drainage Systems, Inc. American Airlines Group, Inc. Adventist Chippewa Valley Hospital American Augers Adventist Health System American Bureau of Shipping Adventist Health System GA Inc. American Century Investments Advocate Health Care American Century Investments ‐ CA Aegis Therapies, LLC American Dental Partners, Inc. AET Inc., Ltd. ‐ AET Offshore Services, Inc. American Enterprise Group, Inc. AET, Inc., Ltd. American Family Insurance Aetna, Inc. American Financial Group, Inc. Affinion Group Holdings, Inc. American Financial Group, Inc. ‐ Great American Financial Aflac, Inc. Resources, Inc. Aflac, Inc. ‐ Communicorp, Inc. American Financial Group, Inc. ‐ Great American Insurance Agero, Inc. Group AgFirst Farm Credit Bank American Financial Group, Inc.
    [Show full text]
  • Stockholm, Sweden November 12, 2020 #Gtrnordics
    Stockholm, Sweden #GTRNordics www.gtreview.com/GTRNordics November 12, 2020 OVERVIEW Once registered, log-in to GTR Connect to network with fellow delegates, download event GTR Nordics returned to Stockholm on November 19, materials and more. 2019, welcoming another record-breaking audience of over 500 trade finance experts, insurers, bankers, ECAs, technology innovators and corporates of all sizes. The event provided a lively forum to discuss the latest strategic As the world’s leading trade, commodity and export developments across key geographical markets and industry sectors, finance publisher and event organiser,GTR offers featuring extensive reflection on the trade and export financing sector’s sponsors and advertisers unrivalled exposure and capability to meet the needs of Nordic corporates despite strong profiling among their peer and client groups.GTR can regulatory headwinds. Discussion pinpointed the impact of trade offer various appealing options that would strategically sanctions and complex KYC compliance demands as some of the and effectively help raise the profile of the partner, most pressing challenges faced in the current climate, with strategic and offer a highly effective platform with which to concerns surrounding CSR and ESG standards, sustainability showcase its capabilities and mission. and trade digitisation also featuring prominently. Broad audience consensus pointed to increasing collaboration and coordination between the market’s key players as a crucial factor in the sector’s capability to maintain relevance. As showcased at GTR Nordics Sponsorship opportunities 2019, standardisation and digitisation are already addressing these pressing issues in areas such as small ticket export finance and Peter Gubbins compliance screening: we’re hugely excited to return to Stockholm Co-founder & CEO in 2020 to hear more on the latest financing innovations optimising [email protected] support for Nordic trade.
    [Show full text]